These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 765895)

  • 1. Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.
    Nutr Rev; 1976 Jan; 34(1):18-20. PubMed ID: 765895
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi.
    Prien EL; Gershoff SF
    J Urol; 1974 Oct; 112(4):509-12. PubMed ID: 4414543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic treatment of oxalate calculi].
    Ljunggren E
    Z Urol Nephrol; 1965 Jul; 58(7):507-12. PubMed ID: 5841716
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium oxalate renal stones.
    Prien EL
    Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.
    Rattan V; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Res; 1994; 22(3):161-5. PubMed ID: 7992461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy in urinary calculi. II. Peroral litholysis and prevention].
    Terhorst B; Melchior H
    Urol Int; 1972; 27(3):230-44. PubMed ID: 5050852
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.
    Gershoff SN; Prien EL
    Am J Clin Nutr; 1967 May; 20(5):393-9. PubMed ID: 6023850
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth studies of calcium oxalate in the presence of various ions and compounds.
    Sutor DJ
    Br J Urol; 1969 Apr; 41(2):171-8. PubMed ID: 4305899
    [No Abstract]   [Full Text] [Related]  

  • 9. [The conservative therapy of urolithiasis (author's transl)].
    Matouschek E; Huber R
    Urologe A; 1979 Jul; 18(4):193-8. PubMed ID: 473452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities of pharmacological prevention of oxalate calculi].
    Terhorst B; Lutzeyer W
    Z Urol Nephrol; 1972 Nov; 65(11):815-25. PubMed ID: 4665913
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phosphate therapy in urolithiasis].
    Dulce HJ
    Urologe; 1965 Jul; 4(4):163-4. PubMed ID: 4284992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical basis of oxalic urolithiasis therapy].
    Górny E
    Postepy Hig Med Dosw; 1976; 30(1):121-32. PubMed ID: 1257164
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on urolithiasis: biochemical and histological studies of vitamin B 6 and magnesium deficiency].
    Kanagawa S
    Nihon Hinyokika Gakkai Zasshi; 1971 Aug; 62(8):592-602. PubMed ID: 5106455
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new drug in the therapy of uric acid calculi].
    Frang D; Berényi M; Babics A
    Z Urol Nephrol; 1974 Feb; 67(2):89-92. PubMed ID: 4847955
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary mucoprotein in pediatric urolithiasis.
    Singhal GD; Singh DN; Gopal SC; Ambasta SS; Gupta RM
    J Pediatr Surg; 1987 Mar; 22(3):218-22. PubMed ID: 3559863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of magnesium oxide and vitamin B6 for the prevention of oxalate urolithiasis].
    Konstantinova OV; Chudnovskaia MV; Ianenko EK; Korolev VV
    Urol Nefrol (Mosk); 1987; (6):12-5. PubMed ID: 3438942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug prevention of recurring urolithiasis].
    Böwering R
    MMW Munch Med Wochenschr; 1974 Jan; 116(1):11-4. PubMed ID: 4204455
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on disturbances of mineral metabolism in oxalurilithiasis and their adjustment].
    Berariu T; Băltescu V; Proinov I; Cătană R
    Urol Int; 1966; 21(4):338-52. PubMed ID: 5959812
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral magnesium intake and its effect on various urinary constituents in the prophylaxis of urolithiasis.
    Kohler FP; Uhle CA
    J Urol; 1966 Nov; 96(5):812-5. PubMed ID: 5923311
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of magnesium and pH on experimental calcium oxalate stone disease.
    Borden TA; Lyon ES
    Invest Urol; 1969 Jan; 6(4):412-22. PubMed ID: 5773525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.